Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology
Abstract
Purpose: Demonstrate a clinical case of poorly differentiated chordoma, confirmed using a wide range of research methods.Material and methods: A 63-year-old female patient with poorly differentiated chordoma who underwent immunohistochemical examination, MRI, CT and scintigraphy.Results: An immunohistochemical study confirmed the morphological affiliation of the tumor, supplemented by the data of imaging methods.Conclusion: The poorly differentiated type of chordoma has a specific immunohistochemical picture, however, differential diagnosis based on imaging methods is currently a difficult task.
Publisher
Non-profit partnership Society of Interventional Oncoradiologists
Reference19 articles.
1. Murphey MD, Andrews CL, Flemming DJ, et al. From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics. 1996;16 (5): 1131-58. DOI: 10.1148/radio-graphics.16.5.8888395.
2. McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12:1-11. DOI: 10.1023/a:1008947301735.
3. Wold LE, Laws ER Jr. Cranial chordomas in children and young adults. J Neurosurg. 1983;59:1043-7. DOI: 10.3171/jns.1983.59.6.1043.
4. Fletcher CDM, Bridge JA, Hogendoorn PCW, et al eds. WHO Classification of Tumours of Soft Tissue and Bone Geneva: WHO Press; 2013.
5. Vujovic S, Henderson S, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157-65. DOI: 10.1002/path.1969.